We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

145 hedge funds and large institutions have $476M invested in Collegium Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 17

101% more call options, than puts

Call options by funds: $395K | Put options by funds: $197K

21% more funds holding

Funds holding: 120 → 145 (+25)

7.42% less ownership

Funds ownership: 101.64% → 94.22% (-7.4%)

16% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 43

18% less capital invested

Capital invested by funds: $580M → $476M (-$104M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
145
Holders Change
+25
Holders Change %
+20.83%
% of All Funds
3.14%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
42
Increased
36
Reduced
43
Closed
17
Calls
$395K
Puts
$197K
Net Calls
+$198K
Net Calls Change
-$678K

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$6.33M
2
RHJA
Rice Hall James & Associates
California
+$4.15M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.09M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.19M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.19M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$19.8M
2
JGC
J. Goldman & Co
New York
-$13.3M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.36M
4
PA
Perceptive Advisors
New York
-$7.37M
5
Macquarie Group
Macquarie Group
Australia
-$5.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$3M -$25.9K -1,619 -0.8%
GIM
27
Granahan Investment Management
Massachusetts
$2.97M +$184K +11,499 +6%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.8M -$42.1K -2,628 -1%
USAA
29
United Services Automobile Association
Texas
$2.74M -$118K -7,370 -4%
Goldman Sachs
30
Goldman Sachs
New York
$2.7M -$544K -33,984 -16%
Charles Schwab
31
Charles Schwab
California
$2.54M +$40.5K +2,530 +2%
American Century Companies
32
American Century Companies
Missouri
$2.42M +$1.69M +105,757 +196%
Citadel Advisors
33
Citadel Advisors
Florida
$2.41M +$795K +49,668 +45%
HCMT
34
Highland Capital Management (Texas)
Texas
$2.09M -$527K -32,900 -19%
1CM
35
1492 Capital Management
Wisconsin
$2.07M -$212K -13,228 -9%
Acadian Asset Management
36
Acadian Asset Management
Massachusetts
$2.07M +$2.19M +136,967 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$2.07M +$2.19M +137,017 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$1.7M +$224K +13,990 +14%
BIM
39
Bogle Investment Management
Massachusetts
$1.48M +$1.57M +97,777 New
TA
40
Teachers Advisors
New York
$1.41M +$249K +15,577 +20%
TCIM
41
TIAA CREF Investment Management
New York
$1.21M +$10.8K +676 +0.9%
SIM
42
Spark Investment Management
New York
$1.2M +$1.27M +79,536 New
PPA
43
Parametric Portfolio Associates
Washington
$1.16M -$407K -25,442 -25%
PAM
44
Panagora Asset Management
Massachusetts
$1.06M +$1.02M +63,549 +938%
Two Sigma Investments
45
Two Sigma Investments
New York
$1.05M +$1.11M +69,072 New
HI
46
HBK Investments
Texas
$1.04M +$502K +31,349 +84%
Millennium Management
47
Millennium Management
New York
$1.03M -$19.8M -1,236,963 -95%
GCP
48
GSA Capital Partners
United Kingdom
$976K -$31.2K -1,948 -3%
Wells Fargo
49
Wells Fargo
California
$927K -$306K -19,096 -24%
Citigroup
50
Citigroup
New York
$914K -$1.56M -97,146 -62%
1
2
3 4 5

COLL Hedge Fund Activity: Q1 2019 in Review

145 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2019, worth a combined $476M — down 18% from $580M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new COLL positions and 17 closed out — a net gain of 25 holders — while 36 added to existing stakes and 43 trimmed.

The largest buyer was Maverick Capital, opening a new position worth an estimated $6.33M. The largest seller was Millennium Management, cutting an estimated $19.8M.

  • 145 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2019, up from 120 in Q4 2018.
  • Funds reported $476M of Collegium Pharmaceutical stock for Q1 2019, down 18% quarter-over-quarter.
  • 42 funds opened new Collegium Pharmaceutical positions in Q1 2019 and 17 closed out, a net change of +25 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2019 was Maverick Capital, an estimated $6.33M added.
  • The largest Collegium Pharmaceutical seller in Q1 2019 was Millennium Management, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2019.